Sign Up to like & get
recommendations!
0
Published in 2024 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noae165.1160
Abstract: Pediatric high-grade gliomas (pHGG) harboring H3.3 K27M/G34R mutations present formidable challenges in treatment due to their aggressiveness and resistance to standard chemotherapy. Our preliminary investigations have shown promising results, indicating that combining 2-deoxyglucose (2DG), a…
read more here.
Keywords:
2dg resistant;
phgg;
g34r mutations;
gliomas ... See more keywords